A. Lavagetto

发表

Final height of girls with Turner's syndrome: correlation with karyotype and parental height

Z. Laron, A. Cohen, R. Kauli, 1995, Acta paediatrica.

Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.

Y. Bertrand, R. Galanello, A. Piga, 2006 .

Phase II clinical evaluation of deferasirox , a once-daily oral chelating agent , in pediatric patients with β-thalassemia major

Y. Bertrand, R. Galanello, A. Piga, 2006 .

Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.

J. Ford, M. Cappellini, R. Galanello, 2006, Haematologica.

Cyclic sex hormone replacement therapy in women undergoing allogeneic bone marrow transplantation: aims and results.

T. Lamparelli, A. Bacigalupo, F. Gualandi, 1991, Bone marrow transplantation.

Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood.

V. Vitale, A. Bacigalupo, A. Rovelli, 1995, Bone marrow transplantation.

Once-Daily Treatment with the Oral Iron Chelator ICL670 (Exjade®): Results of a Phase II Study in Pediatric Patients with β-Thalassemia Major.

Y. Bertrand, R. Galanello, A. Piga, 2004 .

Non-Invasive Measurement of Iron Overload in the Human Body

S. Cuneo, E. Oliveri, S. Cuneo, 2006, IEEE Transactions on Applied Superconductivity.

Pubertal development and fertility in children after bone marrow transplantation.

A. Bacigalupo, S. Chiodi, S. Spinelli, 1991, Bone marrow transplantation.

Ullrich-Turner syndrome with unilateral agenesis of breast, nipple, and pectoralis major.

A. Cohen, C. Romano, A. Lavagetto, 1992, American journal of medical genetics.